company background image
PSG logo

PharmaSGP Holding XTRA:PSG Stock Report

Last Price

€22.60

Market Cap

€271.0m

7D

-1.7%

1Y

-20.1%

Updated

14 Jun, 2024

Data

Company Financials +

PSG Stock Overview

Manufactures and sells over-the-counter drugs and other healthcare products in Germany.

PSG fundamental analysis
Snowflake Score
Valuation4/6
Future Growth2/6
Past Performance5/6
Financial Health5/6
Dividends3/6

PharmaSGP Holding SE Competitors

Price History & Performance

Summary of all time highs, changes and price drops for PharmaSGP Holding
Historical stock prices
Current Share Price€22.60
52 Week High€29.50
52 Week Low€17.70
Beta0.028
1 Month Change-0.88%
3 Month Change-5.83%
1 Year Change-20.14%
3 Year Change0%
5 Year Changen/a
Change since IPO-34.49%

Recent News & Updates

Shareholders Will Be Pleased With The Quality of PharmaSGP Holding's (ETR:PSG) Earnings

May 06
Shareholders Will Be Pleased With The Quality of PharmaSGP Holding's (ETR:PSG) Earnings

Recent updates

Shareholders Will Be Pleased With The Quality of PharmaSGP Holding's (ETR:PSG) Earnings

May 06
Shareholders Will Be Pleased With The Quality of PharmaSGP Holding's (ETR:PSG) Earnings

Some Shareholders Feeling Restless Over PharmaSGP Holding SE's (ETR:PSG) P/E Ratio

Mar 02
Some Shareholders Feeling Restless Over PharmaSGP Holding SE's (ETR:PSG) P/E Ratio

PharmaSGP Holding SE Just Beat Revenue Estimates By 25%

Dec 02
PharmaSGP Holding SE Just Beat Revenue Estimates By 25%

One Analyst Just Shaved Their PharmaSGP Holding SE (ETR:PSG) Forecasts Dramatically

Feb 16
One Analyst Just Shaved Their PharmaSGP Holding SE (ETR:PSG) Forecasts Dramatically

We Think PharmaSGP Holding's (ETR:PSG) Statutory Profit Might Understate Its Earnings Potential

Jan 26
We Think PharmaSGP Holding's (ETR:PSG) Statutory Profit Might Understate Its Earnings Potential

Do Institutions Own PharmaSGP Holding SE (ETR:PSG) Shares?

Dec 04
Do Institutions Own PharmaSGP Holding SE (ETR:PSG) Shares?

Shareholder Returns

PSGDE PharmaceuticalsDE Market
7D-1.7%-0.7%-3.1%
1Y-20.1%-18.1%-0.5%

Return vs Industry: PSG underperformed the German Pharmaceuticals industry which returned -16.8% over the past year.

Return vs Market: PSG underperformed the German Market which returned 1% over the past year.

Price Volatility

Is PSG's price volatile compared to industry and market?
PSG volatility
PSG Average Weekly Movement4.5%
Pharmaceuticals Industry Average Movement5.3%
Market Average Movement5.0%
10% most volatile stocks in DE Market10.3%
10% least volatile stocks in DE Market2.5%

Stable Share Price: PSG has not had significant price volatility in the past 3 months.

Volatility Over Time: PSG's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
201289Natalie Weigandpharmasgp.com

PharmaSGP Holding SE manufactures and sells over-the-counter drugs and other healthcare products in Germany. The company’s pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage creams for the treatment of various pain conditions; RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Revitensin, a drug for the treatment of hair loss; Dorisol for neuralgia (nerve pain), headaches, and migraines; Fulminan, a beauty drink; Lindaven, a pharmaceutical drops to treat their unpleasant problem; and SCLEROCALMAN, a drug for the treatment of clogged cerebral blood vessels. It also offers Prostacalman, a medication for cystitis and urination discomfort in a benign enlarged prostate; Revoten for women with weak connective tissue; Mindalin, a micronutrient drink for a healthy cardiovascular system; MELISTON, a prescription-free tablets to treat anxiety, restlessness, and mood swings; Deruba, a cream for skin redness; Lentisol that prevents the formation of new pigment spots; Neodolor, a headache tablet; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo.

PharmaSGP Holding SE Fundamentals Summary

How do PharmaSGP Holding's earnings and revenue compare to its market cap?
PSG fundamental statistics
Market cap€270.98m
Earnings (TTM)€18.11m
Revenue (TTM)€107.30m

15.0x

P/E Ratio

2.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PSG income statement (TTM)
Revenue€107.30m
Cost of Revenue€9.74m
Gross Profit€97.56m
Other Expenses€79.45m
Earnings€18.11m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.51
Gross Margin90.93%
Net Profit Margin16.88%
Debt/Equity Ratio163.9%

How did PSG perform over the long term?

See historical performance and comparison

Dividends

6.0%

Current Dividend Yield

90%

Payout Ratio

Does PSG pay a reliable dividends?

See PSG dividend history and benchmarks
When do you need to buy PSG by to receive an upcoming dividend?
PharmaSGP Holding dividend dates
Ex Dividend DateJun 27 2024
Dividend Pay DateJul 01 2024
Days until Ex dividend11 days
Days until Dividend pay date15 days

Does PSG pay a reliable dividends?

See PSG dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.